What happened
Insilico Medicine released a benchmarking service designed to test third-party AI tools for drug discovery. The platform allows external developers and researchers to evaluate model performance against standardized tests. The service aims to create clearer standards for measuring AI accuracy in early-stage medicine design.
The context
Evaluating AI models in biology is notoriously hard due to a lack of standard testing baselines. Providing a dedicated evaluation service helps biotech teams verify if a model actually works before investing in expensive lab trials.
Sources
- AllSci ↗ via Google News Reported